Dear colleagues, Please share and disseminate through your network. On behalf of all the organizers, I am happy to announce that registrations are now open for the EMBO Workshop on “Astrocytes: From Molecules to Systems,” which will take place at the exclusive setting of the Venice International University on San Servolo Island in Venice (Italy) on April 14–18, 2025. https://meetings.embo.org/event/25-astrocytes The EMBO Workshop Astrocytes: From Molecules to Systems is the first international meeting dedicated to astrocytes. It showcases an exceptional line-up of renowned investigators in the field of astrocyte biology to provide a multidisciplinary, comprehensive view of astrocyte research aimed at spurring research in the field for the next decade. Participation in the conference is limited to 160 attendees. The primary selection criterion is the quality of the scientific work. A scientific committee, composed of the Organizers and workshop speakers, will evaluate submitted abstracts based on their relevance to the astrocyte field and alignment with the workshop topics. The presentation of unpublished data is encouraged and will be given priority. We strongly encourage participation from PhD students and postdocs. Selected abstracts will be chosen for short talks, flash talks, and/or poster sessions. Registration: To enroll in selections and access the meeting, please pre-register through the website at the end of this message by January 14, 2025. Confirmed Speakers (in alphabetical order): Amit Agarwal, Heidelberg University, Germany Nicola Allen, Salk Institute for Biological Studies, USA Amaia Arranz, Achucarro Basque Center for Neuroscience, Spain Blanca Díaz Castro, University of Edinburgh, UK Won-Suk Chung, Korea Advanced Institute of Science and Technology, South Korea Laura Civiero, University of Padua, Italy Carmen Falcone, International School for Advanced Studies, Italy Tommaso Felin, Italian Institute of Technology, Italy Fiona Doetsch, University of Basel, Switzerland Bart de Strooper, University College London, UK Maurizio De Pittà, Krembil Research Institute, Canada Blanca Díaz Castro, University of Edinburgh, UK Carole Escartin, CNRS University of Paris-Saclay, France Cristina García Cáceres, German Research Center for Environmental Health, Germany Angela Giangrande, University of Strasbourg, France Inbal Goshen, The Hebrew University, Israel Naomi Habib, The Hebrew University, Israel Dieter Heiland, Medical Center University of Freiburg, Germany Elly Hol, University Medical Center Utrecht Brain Center, The Netherlands Matthew Holt, Institute for Research and Innovation in Health, Portugal Dolores Irala, Duke University Medical Center, USA Stephan Kaeser, Hertie Institute for Clinical Brain Research, Germany Baljit Khakh, University of California Los Angeles, USA Ksenia Kastanenka, Massachusetts General Hospital, Harvard Medical School, USA Martin Kampmann, University of California, USA Andràs Lakatos, University of Cambridge, UK Pierre Magistretti, King Abdullah University of Science and Technology, Saudi Arabia Keith Murai, McGill University Health Center, Canada Marta Navarrete, Instituto Cajal CSIC, Spain Valentin Nägerl, University of Bordeaux, France Nathalie Rouach, College de France, France Francisco Quintana, Brigham and Women’s Hospital, Harvard Medical School, USA Aiman Saab, University of Zurich, Switzerland Eduardo Zimmer, Universidade Federal do Rio Grande do Sul, Brazil EMBO Workshop “Astrocytes: From Molecules to Systems” Apr 14–18, 2025 Venice (Italy) https://meetings.embo.org/event/25-astrocytes Thank you for your consideration of the matter. Maurizio De Pitta ----- Maurizio DE PITTA Principal Investigator Neuron-Glia Interactions Lab (NGILab) Krembil Research Institute, 4KD-509 60 Leonard Ave, Toronto, ON M5T 0S8, CA +1.416.603.5800 ext. 3290 This e-mail may contain confidential and/or privileged information for the sole use of the intended recipient. Any review or distribution by anyone other than the person for whom it was originally intended is strictly prohibited. If you have received this e-mail in error, please contact the sender and delete all copies. Opinions, conclusions or other information contained in this e-mail may not be that of the organization. If you feel you have received an email from UHN of a commercial nature and would like to be removed from the sender's mailing list please do one of the following: (1) Follow any unsubscribe process the sender has included in their email (2) Where no unsubscribe process has been included, reply to the sender and type "unsubscribe" in the subject line. If you require additional information please go to our UHN Newsletters and Mailing Lists page. Please note that we are unable to automatically unsubscribe individuals from all UHN mailing lists. Patient Consent for Email: UHN patients may provide their consent to communicate with UHN about their care using email. All electronic communication carries some risk. Please visit the UHN website and search “Using email to Communicate with Your UHN Health Care Team” to learn about the risks of electronic communication and how to protect your privacy. You may withdraw your consent to receive emails from UHN at any time. Please contact your care provider, if you do not wish to receive emails from UHN.